Occurrence of neuritis among leprosy patients: Survival analysis and predictive factors;Ocorrência de neurite em pacientes com hanseníase: Análise de sobrevida e fatores preditivos

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 5, 2008, Pages 464-469

  Gonçalves, Soraya Diniz ^a,c   Sampaio, Rosana Ferreira ^b   Antunes, Carlos Maurício De Figueiredo ^b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c NONE   (Brazil)

Author keywords

Leprosy; Neuritis; Risk factors

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LEPROSY; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; NEURITIS; RISK FACTOR; SURVIVAL RATE;

ADULT; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LEPROSY; MALE; NEURITIS; TIME FACTORS;

EID: 56549117985     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000500006     Document Type: Article

References (21)

1. Birdi TJ, Antia NH. Mechanisms involved in peripheral nerve damage in leprosy with special reference to insights obtained from in vitro studies and the experimental mouse model. International Journal of Leprosy 71: 345-354, 2003.
2. Carvalho MS, Andreozzi VL, Codeço CT, Barbosa MTS, Shirnakura SE. Análise de sobrevida. Teoria e Aplicações em Saúde. Editora Fundação Oswaldo Cruz, Rio de Janeiro, 2005.
3. Charosky CB, Gatti JC, Cardama JE. Neuropathies in Hansen's disease (editorials). International Journal of Leprosy 51: 576-586, 1983.
4. Croft RP, Nicholls PG, Steyerberg EW, Richardua JH, Smith WCS. A clinical prediction rule for nerve-function impairment in leprosy patients. The Lancet 355:1603-1606, 2000.
5. Croft RP, Richardus JH, Nicholls PG, Smith WCS. Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study). Leprosy Review 70: 140-159, 1999.
6. Deepak S. Answering the rehabilitation needs of leprosy affected persons in integrated setting through primary health care services and community based rehabilitation. Indian Journal Leprosy 75:127-142, 2003.
7. Foss NT, Souza CS, Gourlart IMB, Gonçalves HS, Virmond M. Hanseníase: episódios reacionais. Projeto diretrizes. Associação Médica Brasileira e Conselho Federal de Medicina. 2003.
8. Guocheng Z, Wenzhong L, Liangbin Y, Zhongmin Y, Yiangsheng C, Tisheng Z, Ganyun Y. An epidemiological survey of deformities and disabilities among 14.257 cases of leprosy in 11 counties. Leprosy Review 64: 143-149, 1993.
9. Kumar B, Dogra S, Kaur I. Epidemiological characteristics of leprosy reactions: 14 years experience from North India. International Journal of Leprosy 72:125-133, 2004.
10. Kumar V, Sengupta U. Ultrastructural Study of Schwann Cells and Endotelial Cells in the Patogenesis of Leprous Neuropathy. International Journal of Leprosy 71:328-340, 2003.
11. Makino M, Maeda Y, Ishii N. Immunostimulatory activity of major membrane protein-II from Mycobacterium leprae. Cellular Immunology 233:53-60, 2005.
12. Meima A, Sauderson PR, Gebre S, Desta K, Van Oortmarssen GJ, Hablema JDF. Factors associated with impairments in new leprosy patients: the AMFES cohort. Leprosy Review 70:189-203, 1999.
13. Rambukkana A. Molecular basis for the peripheral nerve predilection of Mycobacterium leprae. Current Opinion in Microbiology 4:21-27, 2001.
14. Saunderson P, Gebre S, Desta K, Byass P, Lockwood DNJ. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and autcome. Leprosy Review 71: 285-308, 2000.
15. Selvaraj G, Prabakar N, Muliyil J, Martin G. Incidence of disabilities among multi-bacillary cases after initiation of multidrug therapy and factors associated with the risk of developing disabilities. Indian Journal Leprosy 70 (suppl):11-16, 1998.
16. Sharma P, Beena HK, Kaur H, Narayan R. Disabilities in multibacilary leprosy patients: before, during and after multidrug therapy. Indian Journal Leprosy 68:127-136, 1996.
17. Shetty VP, Mistry NF, Antia NH. Current understanding of leprosy as a peripheral nerve disorder: significance of involvement of peripheral nerve in leprosy. Indian Journal Leprosy 72:339-350, 2000.
18. Spierings E, Boer TD, Zulianello L, Ottenhoff THM. Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium Leprae. Immunology and Cell Biology 78:349-355, 2000.
19. Statistical Package for the Social Sciences incorporation. SPSS for Windows. Release 12.0. SPSS Inc., Chicago, 2003.
20. Van Brakel WH. Detecting peripheral nerve damage in the field our tools in 2000 and beyond. Indian Journal Leprosy 72:47-64, 2000.
21. Van Brakel WH. Peripheral neuropathy in leprosy and its consequences. Leprosy Review 71: S146-S153, 2000.